TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 91 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2016. The put-call ratio across all filers is 1.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $2,137,000 | -65.9% | 461,510 | -26.2% | 0.04% | -62.7% |
| Q4 2015 | $6,274,000 | +34.5% | 625,510 | 0.0% | 0.11% | +41.0% |
| Q3 2015 | $4,666,000 | -90.0% | 625,510 | -36.4% | 0.08% | -76.6% |
| Q2 2015 | $46,680,000 | +162.1% | 984,000 | +102.5% | 0.33% | +31.5% |
| Q1 2015 | $17,807,000 | +471.7% | 486,000 | +519.6% | 0.25% | +452.2% |
| Q4 2014 | $3,115,000 | +55.9% | 78,440 | -21.6% | 0.05% | +58.6% |
| Q3 2014 | $1,998,000 | – | 100,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 293,675 | $14,061,000 | 4.76% |
| BB BIOTECH AG | 1,507,114 | $71,497,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 893,076 | $42,368,000 | 1.77% |
| Opaleye Management Inc. | 65,000 | $3,084,000 | 1.23% |
| COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 390,294 | $18,515,000 | 1.14% |
| Granite Point Capital Management, L.P. | 75,206 | $3,568,000 | 1.04% |
| Granahan Investment Management | 705,601 | $33,474,000 | 0.95% |
| Iguana Healthcare Management, LLC | 50,000 | $2,372,000 | 0.75% |
| Eventide Asset Management | 290,000 | $13,758,000 | 0.74% |
| Rhenman & Partners Asset Management AB | 107,400 | $5,095,000 | 0.61% |